Navigation Links
With Prostate Cancer: Waiting for Symptoms Is Not an Option
Date:7/1/2008

NEW YORK, July 1 /PRNewswire/ -- Prostate cancer is the second leading cause of death among American males, but when caught early, prostate cancer has a 90% cure rate.

According to Dr. David Samadi, Chief, Division of Robotics and Minimally Invasive Surgery, Department of Urology, at Mount Sinai Medical Center, "The key to fighting prostate cancer is not to wait until there are warning signs, because by then it may be too late."

The tendency of prostate cancer to grow without causing noticeable symptoms leads doctors to recommend that men over 50 get screened every year. However, Dr. Samadi recommends that anyone with a strong family history of the disease or other risk factors get screened at age 40.

Routine screening for prostate cancer consists of a PSA (prostate-specific antigen) blood test and a digital rectal exam. Most doctors regard a PSA score of less than 4.0 as normal, however, Dr. Samadi regards a jump in PSA velocity to be a warning sign. For example, an increase in the PSA velocity from 0.8 one year to 1.6 the following may be a red flag requiring a biopsy to test for cancer cells. If there is need for treatment, there are surgical options for removal of the prostate with varying outcomes that can dramatically impact the recovery process and quality of life.

"The most common treatment for prostate cancer is surgical removal of the prostate or prostatectomy traditionally done by open surgery," Dr. Samadi says. "While results of open surgery are generally excellent, there are distinct downsides. For one thing, the surgeon makes an 8- to 10-inch incision to remove a 2-inch organ, which causes enough blood loss that about 20 percent of patients require a blood transfusion. That large incision also means more pain and a higher risk of infection."

Robotic prostate surgery is virtually "bloodless" and involves five small "keyhole" incisions in the patient's abdomen, through which fine instruments are inserted, along with a miniscule camera that displays magnified images from inside the body. The robotic control system enables the surgeon's hand movements to be more precise, resulting in less trauma to surrounding tissue, and minimal blood loss. Men who opt for robotic laparoscopic surgery are cancer free and able to resume normal lifestyles with total control over their sexual functions and bladder. Cancer free outcomes also result from traditional open prostate surgery, but men are rendered impotent and incontinent -- both of which may never be reversed. These side effects are devastating to prostate cancer patients, and have led to failed marriages and relationships, and depression.

Instead of two to three days of hospitalization and two months of recuperation typical with open surgery, robotic surgery patients go home the next day and are back to normal activities within two weeks. These patients have an excellent chance of being cancer-free with great quality of life. For more information, call 212-241-8779 or log on to http://www.roboticoncology.com.

Media Contact: Cathy Callegari -- 212-579-1370 or cathy@callprinc.com


'/>"/>
SOURCE Dr. David Samadi, Mount Sinai Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: